Cites

Teramot is a developer of autonomous AI agents that assist companies in navigating, organizing, and understanding their data. Their AI software infrastructure enables quick access to information, enhancing decision-making processes with minimal effort. By leveraging repeated use, the software learns and adapts, allowing businesses worldwide to effectively address the challenges of information accessibility, ensuring that users can retrieve and utilize data when and how they need it.

NeuroAcoustics focuses on treating neurological conditions through the management of brain waves during sleep using personalized, user-friendly devices. The company designs at-home products that cater to a range of issues, including enhancing cognitive function in older adults and individuals with mild cognitive impairment. By providing simple solutions, NeuroAcoustics aims to help users improve both their cognitive state and sleep quality.

Ergo Bioscience is a biotech start-up that specializes in the precise fermentation of plant cells to develop essential animal proteins, specifically myoglobin and casein. The company aims to innovate within the food sector by creating realistic plant-based meat and dairy alternatives that enhance the taste, texture, and aroma of these products. By harnessing the power of science and nature, Ergo Bioscience seeks to provide environmentally friendly solutions that cater to the growing demand for plant-based options, ultimately transforming the consumer experience in the meat- and dairy-free market.

EpiLiquid is a company focused on early cancer detection through the use of liquid biopsies that identify specific biomarkers. By developing a platform for personalized medicine, EpiLiquid aims to enhance the screening, diagnosis, and follow-up care of cancer patients. This innovative approach enables healthcare providers to tailor treatments more effectively, improving the likelihood of successful patient outcomes.

Selectivity Life is a healthcare company which develops reproductive medical devices which bring fertility treatments to patients' homes.

Limay Biosciences specializes in the development of innovative molecular testing solutions aimed at enhancing food quality and health decision-making. The company creates simple, precise, and cost-effective tools that facilitate on-site testing of various DNA, RNA, and protein targets. By leveraging advanced biotechnologies, Limay Biosciences provides businesses with automated and accessible testing services, allowing for real-time analysis and improved decision-making in diverse applications.

Stradot specializes in developing high-speed, eco-friendly parking systems aimed at enhancing the efficiency and capacity of existing parking lots. By utilizing an autonomous robotic system, Stradot's technology allows for the densification of surface parking operations without the need for permanent infrastructure. This innovative approach enables clients to recover up to half the space in their parking facilities, significantly increasing the number of vehicles that can be accommodated in crowded urban areas while also reducing operational costs.

Crinsurance specializes in advanced preservation systems for reproductive materials, specifically embryos and gametes. The company has developed a cryotank that safely stores these materials in liquid nitrogen without the need for regular refills, a significant improvement over traditional cryobanks. This innovative technology not only enhances the safety of eggs, sperm, and embryos during the freezing process but also allows for digital tracking, thereby streamlining operations for IVF laboratories. By improving the preservation and management of reproductive materials, Crinsurance aims to increase fertility success rates and optimize efficiency in assisted reproductive technology.

ViewMind is a digital health and artificial intelligence company focused on neurocognitive health assessments. The company has developed a non-invasive device that analyzes eye movement patterns to predict the onset of Alzheimer's disease and other cognitive disorders. By employing advanced algorithms, ViewMind quantifies cognitive performance, assessing executive, attentional, and memory functions. This technology enables healthcare professionals to detect minor changes in cognitive performance over short periods, providing valuable data for diagnosing neurocognitive disorders. Through its innovative approach, ViewMind aims to enhance the accuracy of brain health evaluations and improve early detection of cognitive decline.

Eolo Pharma focuses on developing molecular drugs aimed at curing chronic inflammation. The company specializes in researching and creating medicines that target the molecular and cellular mechanisms underlying inflammation-related diseases. By concentrating on this area, Eolo Pharma aims to create innovative therapies that address significant health challenges and contribute to the treatment and prevention of leading causes of death. Their work seeks to introduce new types of drugs and therapies into the healthcare industry, enhancing the options available for managing these conditions.

RadBio is focused on developing a therapeutic platform aimed at treating fibrotic disorders and solid tumors that currently lack effective treatments. The company has created a neutralizing biomolecule in the form of an Fc-fusion protein, which specifically targets and neutralizes excess TGF-β. This innovative approach allows for the modulation of TGF-β without disrupting its signaling cascade, offering potential therapeutic benefits for a range of fibrotic conditions and cancers. RadBio is exploring various applications of its biomolecule to address the unmet medical needs associated with these diseases.

Bionirs specializes in developing light-based biomedicine technology aimed at enhancing the quality of life through innovative medical imaging solutions. The company has created MamoRef, a non-invasive optical system that provides a simple, affordable, and painless alternative for mammograms. Utilizing infrared light in diffuse reflectance geometry, Bionirs’ platform allows for a more accessible approach to mammography, ensuring that patients can undergo necessary screenings without discomfort or high costs.

ARDAN PHARMA is a biotechnology company focused on discovering and developing innovative drugs to address unmet medical needs in oncology. The company has a scientific team with over ten years of expertise in immune system modulation, resulting in a portfolio of potential new oncology therapies. ARDAN PHARMA's compounds are designed to control inflammasome activation in cancer immunotherapy, aiming to overcome resistance to existing treatments. These compounds have demonstrated strong anti-tumoral immunity in various in vivo models, including melanoma, lymphoma, colon, and lung cancer. The company's technology enhances the effectiveness of immunotherapies by synergizing with immune checkpoint blockade and Bcl-2 antagonists. Through its commitment to developing first-in-class compounds targeting emerging molecular pathways, ARDAN PHARMA seeks to transform cancer treatment and improve patient outcomes.

Gbot is a company focused on revolutionizing traditional plant breeding and weed management through innovative technology. It has developed an autonomous robot that effectively controls weeds without the use of agrochemicals. This robot also functions as a sophisticated tool for phenotyping plants in experimental plots, providing high-quality data that allows plant breeders to make informed decisions. By integrating robotics and Internet of Things (IoT) devices, Gbot's technology facilitates reliable in-situ measurements, enabling breeders to accurately assess environmental variables that may impact the quality of their tests. Through these advancements, Gbot aims to enhance agricultural practices and promote sustainable farming methods.

iMvalv is a medical device company based in Santa Fe, Argentina, focused on developing innovative solutions for glaucoma patients. The company has created a microvalve that regulates intraocular pressure through an implanted chip, which helps prevent blindness and preserve vision. This biocompatible device is designed to be small and energy-efficient, offering telemetric control for effective treatment without the risk of clogging. By addressing the damage to the optic nerve associated with glaucoma, iMvalv aims to enhance the quality of care for patients suffering from this condition.

Nectras is an agricultural technology company based in Argentina that specializes in pest management solutions. The company has developed an integrated system that utilizes electronic sensors and drones to detect, evaluate, and address pest outbreaks in crops. By deploying real-time IoT sensors, Nectras identifies pests and processes this data through its cloud-based software platform. This allows farmers to monitor pest control services continuously and effectively apply agrochemicals only where needed. The innovative approach not only reduces costs associated with conventional pest management but also promotes environmentally sustainable practices by minimizing chemical usage. Overall, Nectras aims to enhance crop yields while safeguarding the environment.

Phylumtech S.A., founded in 2009 and based in Sunchales, Argentina, specializes in providing drug discovery solutions. The company offers innovative products such as WMicroTracker-One, which automatically quantifies the behavior of small animals in microtiter plates, and WMicroTracker Arena, designed to measure the movement of single or groups of animals with enhanced accuracy and resolution. Phylumtech's platform aims to streamline drug development processes, reduce costs, and deliver fast, reliable results, thereby assisting researchers, laboratories, and the pharmaceutical industry in the discovery of new molecules.